Effects of ALCAR on the fast axoplasmic transport in cultured sensory neurons of streptozotocin-induced diabetic rats

Neuroscience Research

Volumn 33, Issue 3, 1999, Pages 207-213

  Kano, Masato ^a   Kawakami, Tadashi ^b   Hori, Hideaki ^a   Hashimoto, Yoko ^a   Tao, Yang ^a   Ishikawa, Yoshihiro ^a   Takenaka, Toshifumi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acetyl L carnitine (ALCAR); Diabetic neuropathy; Dorsal root ganglion; Fast axoplasmic transport; Neuron; Rat

Indexed keywords

LEVACECARNINE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AXOPLASM; AXOPLASM FLOW; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; LYSOSOME; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RETROGRADE NERVE FIBER TRANSPORT; SENSORY NERVE CELL; SPINAL GANGLION; STREPTOZOCIN DIABETES;

EID: 0032891398     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-0102(99)00012-7     Document Type: Article

References (43)

1. Abbete S.L., Atkinson M.B., Breuer A.C. Amount and speed of fast axonal transport in diabetes. Diabetes. 40:1991;111-117.
2. Allen R.D., Allen N.S. Video-enhanced microscopy with a computer frame memory. J. Microsc. 129:1983;3-17.
3. Brown M.J., Asbury A.K. Diabetic neuropathy. Ann. Neurol. 15:1984;2-12.
4. Brown M.J., Sumner A.J., Greene D.A., Diamond S.M., Asbury A.K. Distal neuropathy in experimental diabetes mellitus. Ann. Neurol. 8:1980;168-178.
5. Carta A., Calvani M., Bravi D., Bhuachalla S.N. Acetyl-L-carnitine and Alzheimer's disease: pharmacological considerations beyond the cholinergic sphere. Ann. NY Acad. Sci. 695:1993;324-326.
6. Castorina M., Ferraris L. Acetyl-L-carnitine affects aged brain receptorial system in rodents. Life Sci. 54:1994;1205-1214.
7. Castorina M., Ambrosini A.M., Giuliani A., Pacifici L., Ramacci M.T., Angelucci L. A cluster analysis study of acetyl-L-carnitine effect on NMDA receptors in aging. Exp. Gerontol. 28:1993;537-548.
8. De Simone R., Ramacci M.T., Aloe L. Effect of acetyl-L-carnitine on forebrain cholinergic neurons of developing rats. Int. J. Dev. Neurosci. 9:1991;39-46.
9. Di Giulio A.M., Lesma E., Gorio A. Diabetic neuropathy in the rat: 1. Alcar augments the reduced levels and axoplasmic transport of substance P. J. Neurosci. Res. 40:1995;414-419.
10. Finegold D., Lattimer S.A., Nolle S., Bernstein M., Greene D.A. Polyol pathway activity and myo-inositol metabolism: a suggested relationship in the pathogenesis of diabetic neuropathy. Diabetes. 32:1983;988-992.
11. Florio T., Meucci O., Grimaldi M., Ventra C., Cocozza E., Avallone A., Postiglione A., Marino A., Schettini G. Effect of acetyl-L-carnitine treatment on brain adenylate cyclase activity in young and aged rats. Eur. Neuropsychopharmacol. 3:1993;95-101.
12. Gabbay K.H. The sorbitol pathway and complications of diabetes. New Engl. J. Med. 288:1973;831-836.
13. Gotoh H., Kano M. Transport and supply of synaptic vesicles. Mebio. 10:1993;49-58. Tokyo.
14. Greene D.A., Lattimer S.A. Action of sorbinil in diabetic peripheral nerve relationship of polyol (sorbitol) pathway inhibition to a myo-inositol-mediated defect in sodium-potassium ATPase activity. Diabetes. 33:1984;712-716.
15. Greene D.A., Winegrad A.L. Effects of acute experimental diabetes on composite energy metabolism in peripheral nerve axons and Schwann cells. Diabetes. 30:1981;967-974.
16. Greene D.A., De Jesus P.V., Winegrad A.L. Effect of insulin and dietary myo-inositol on impaired peripheral moter nerve conduction velocity in acute streptozotocin diabetes. J. Clin. Invest. 55:1975;1326-1336.
17. Hashimoto Y., Hori H., Kawakami T., Kusakabe T., Takenaka T. Effect of dibutyryl cyclic AMP on axoplasmic transport in the hippocampus. Brain Res. 755:1997;343-346.
18. Hori H., Kawakami T., Takenaka T. Light microscopic measurement of axoplasmic transport. J. Physiol. Soc. Jpn. 58:1996;283-300.
19. Jakobsen J., Sidenius P. Decreased axoplasmic transport of structural proteins in streptozotocin diabetic rats. J. Clin. Invest. 66:1980;292-297.
20. Kano M., Tashiro H., Kawakami T., Takenaka T., Gotoh H. Differential suppression of axoplasmic transport: effects of light irradiation to the growth cone of cultured dorsal root ganglion neurons. Cell. Mol. Neurobiol. 15:1995;297-306.
21. Kawakami T., Hikawa N., Kusakabe T., Kano M., Bandou Y., Gotoh H., Takenaka T. Mechanism of inhibitory action of capsaicin on particulate axoplasmic transport in sensory neurons in culture. J. Neurobiol. 24:1993;545-551.
22. Kawakami T., Takenaka T., Hori H., Hashimoto Y., Kusakabe T. Effects of acetylcholine and adrenaline on axoplasmic transport at different regions of mouse superior cervical ganglion cells in culture. Brain Res. 683:1995;88-92.
23. LaVail J.H., LaVail M.M. Retrograde axonal transport in the central nervous system. Science. 176:1972;1416-1417.
24. Maeda K., Kikkawa R. Drug treatment of diabetic neuropathy. Neurol. Med. 39:1993;136-142. Tokyo.
25. Norido F., Canella R., Zanoni R., Gorio A. Development of diabetic neuropathy in the C57BL/Ks (db/db) mouse. Exp. Neurol. 83:1984;221-232.
26. Piovesan P., Pacifici L., Taglialatela G., Ramacci M.T., Angelucci L. Acetyl-L-carnitine treatment increases choline acetyltransferase activity and NGF levels in the CNS of adult rats following total fimbria-fornix transection. Brain Res. 633:1994;77-82.
27. Piovesan P., Quatrini G., Pacifici L., Taglialatela G., Angelucci L. Acetyl-L-carnitine restores choline acetyltransferase activity in the hippocampus of rats with partial unilateral fimbria-fornix transaction. Int. J. Dev. Neurosci. 13:1995;13-19.
28. Prickaerts J., Blokland A., Honig W., Meng F., Jolles J. Spatial discrimination learning and choline acetyltransferase activity in streptozotocin-treated rats: effects of chronic treatment with acetyl-L-carnitine. Brain Res. 674:1995;142-146.
29. Robinson J.P., Willars G.B., Tomlison D.R., Keen P. Axonal transport and tissue contents of substance P in rats with long term streptozotocin-diabetes. Effect of the aldose reductase inhibitor 'Statil'. Brain Res. 426:1987;339-348.
30. Sango K., Horie H., Sotelo J. R., Takenaka T. A high glucose environment improves survival of diabetic neurons in culture. Neurosc. Lett. 129:1991;277-280.
31. Sidenius P., Jakobsen J. Reversibility and preventability of the decrease in slow transport velocity in experimental diabetes. Diabetes. 31:1982;689-693.
32. Sidenius P. The axonopathy of diabetic neuropathy. Diabetes. 31:1982;356-363.
33. Taglialatela G., Angelucci L., Ramacci M.T., Werrbach-Perez K., Jackson G.R., Perez-Polo J.R. Stimulation of nerve growth factor receptors in PC12 by acetyl-L-carnitine. Biochem. Pharmacol. 44:1992;577-585.
34. Takenaka T., Kawakami T., Hikawa N., Gotoh H. Axoplasmic transport of mitochondria in cultured dorsal root ganglion cells. Brain Res. 528:1990;285-290.
35. Takenaka T., Kawakami T., Hori H., Bando Y. Effect of neurotransmission on axoplasmic transport: how adrenaline affects superior cervical ganglion cells. Brain Res. 643:1994;81-85.
36. Thomas P.K., Lascells R.G. The pathology of diabetic neuropathy. Q. J. Med. 35:1966;489-509.
37. Tomlinson D.R., Willars G.B., Calthrop-Owen E.F. Defects of axonal transport in experimental diabetes that are unrelated to the sorbitol pathway. Exp. Neurol. 96:1987;194-202.
38. Tsukita S., Ishikawa H. The movement of membranous organelles in axons. Electron microscopic identification of anterogradely and retrogradely transported organelles. J. Cell Biol. 84:1980;513-530.
39. Vitadello M., Couraud J.Y., Hassing R., Gorio A., Di Giamberardino L. Axonal transport of acetylcholinesterase in the diabetic mutant mouse. Exp. Neurol. 82:1983;143-147.
40. Vitadello M., Filliatreau G., Dupont J.L., Hassing R., Gorio A., Di giamberardino L. Altered axonal transport of cytoskeletal proteins in the mutant diabetic mouse. J. Neurochem. 45:1985;860-868.
41. Winter J. Characterization of capsaicin-sensitive neurons in adult rat dorsal root ganglion cultures. Neurosci. Lett. 80:1987;134-140.
42. Yagihashi S., Kudo K., Nishihira M. Peripheral nerve structures of experimental diabetes rats and the effect of insulin treatment. Tohoku J. Exp. Med. 127:1979;35-44.
43. Yagihashi S., Kamijo M., Watanabe K. Reduced myelinated fiber size correlates with loss of axonal neurofilaments in peripheral nerve of chronically streptozotocin diabetic rats. Am. J. Pathol. 136:1990;1365-1373.